First Regeneron doses for use by Covid patients arrive in Czechia

The first delivery of the drug Regeneron, used for patients at risk of developing a severe case of Covid-19, has arrived in the Czech Republic. Deliveries to hospitals should begin next week.

The Ministry of Health in early March authorized the use of the as yet unregistered drug, granting an exemption for 12,000 doses. Its use has been recommended by the Institute for Drug Control.